Clinical Trials on Mesothelioma; Peritoneum
Total 2084 results
-
ARCAGY/ GINECO GROUPCompletedOvarian Cancer | Fallopian Tube Cancer | Malignant Tumor of PeritoneumFrance
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung Carcinoma | Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural MesotheliomasUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI); BiogenCompletedPleural Mesothelioma | Metastatic Pleural EffusionsUnited States
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma
-
National Cancer Institute (NCI)CompletedEpithelioid Mesothelioma | Cholangiocarcinoma, Extrahepatic | Neoplasms With Mesothelin Expression | Adenocarcinoma, PancreaticUnited States
-
Charite University, Berlin, GermanyGerman Cancer AidCompletedMalignant Neoplasm of Stomach | Secondary Malignant Neoplasm of Peritoneum | Secondary Malignant Neoplasm of Other and Unspecified SitesGermany
-
Roswell Park Cancer InstituteLumeda,Inc.Active, not recruitingMalignant Mesothelioma | Non-Small Cell Lung Carcinoma | Pleural DisorderUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Recurrent Pleural Malignant Mesothelioma | Stage III Pleural Malignant Mesothelioma AJCC v7 | Stage IV Pleural Malignant Mesothelioma AJCC v7 | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | HLA-A*0201 Positive... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Dana-Farber Cancer Institute; Novartis PharmaceuticalsCompletedMalignant Pleural MesotheliomaUnited States
-
Incyte CorporationWithdrawnAdvanced and/or Metastatic Solid Tumors | Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer | Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Sheffield Hallam UniversityNot yet recruitingPancreatic Cancer | Mesothelioma; LungUnited Kingdom
-
NanoAlvandCompletedNon Small Cell Lung Cancer | Malignant Pleural Mesothelioma
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
Asbestos Diseases Research FoundationEnGeneIC LimitedCompletedNon-Small Cell Lung Cancer | Malignant Pleural MesotheliomaAustralia
-
Nevada Cancer InstituteTerminatedNon-Small Cell Lung Cancer and Pleural MesotheliomaUnited States
-
CHU de ReimsCompletedPatients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based ChemotherapyFrance
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Recurrent Ovarian Epithelial Cancer | Malignant Tumor of PeritoneumUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Rhabdomyosarcoma | Refractory Rhabdomyosarcoma | Recurrent Colon Carcinoma | Recurrent Gastric Carcinoma | Recurrent Rectal Carcinoma | Refractory Sarcoma | Refractory Ovarian Carcinoma | Resectable... and other conditionsUnited States
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingMesotheliomaUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer CenterTerminatedMesotheliomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMesotheliomaBrazil, United States, China, Italy, Australia, Belgium, Chile, Colombia, France, Germany, Greece, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, South Africa, Switzerland, Turkey, United Kingdom
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Brynn ChappellThe Christie NHS Foundation TrustTerminatedMesotheliomaUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Terminated
-
Medias Klinikum for Surgical OncologyCompletedMesothelioma
-
Eskisehir Osmangazi UniversityCompleted
-
Armando Santoro, MDCompleted
-
Eli Lilly and CompanyApproved for marketingALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.MesotheliomaUnited States, Brazil, Egypt, Saudi Arabia
-
Power Life Sciences Inc.Not yet recruiting
-
University Health Network, TorontoOICRRecruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Amphera BVTMC PharmaCompletedMesotheliomaNetherlands, France, United Kingdom, Belgium, Italy
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC; Intergroupe Francophone de Cancerologie Thoracique; National...Active, not recruitingMesotheliomaFrance, Canada, Italy
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Mayo Clinic; Brigham and Women's Hospital; Princess...Active, not recruiting
-
University of HullCompletedLung Neoplasm Malignant | Mesothelioma; LungUnited Kingdom
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedMesotheliomaUnited States
-
Mayo ClinicCSA Medical, Inc.Terminated
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
Jonsson Comprehensive Cancer CenterWithdrawnMesotheliomaUnited States
-
National Cancer Institute (NCI)Completed
-
BayerImmunoGen and MorphoSysCompletedMesotheliomaBelgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
-
University of Texas Southwestern Medical CenterUniversity of Chicago; Columbia University; Duke UniversityCompletedMesotheliomaUnited States
-
Istituto Clinico HumanitasCompletedMesothelioma, MalignantItaly
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknown
-
Royal Brompton & Harefield NHS Foundation TrustUniversity of Bristol; National Institute for Health Research, United KingdomUnknown